nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCB1—ovarian cancer	0.211	1	CbGaD
Nelfinavir—SLCO1A2—Chlorambucil—ovarian cancer	0.141	0.225	CbGbCtD
Nelfinavir—ABCG2—Topotecan—ovarian cancer	0.0732	0.117	CbGbCtD
Nelfinavir—ABCG2—Paclitaxel—ovarian cancer	0.0362	0.0577	CbGbCtD
Nelfinavir—ABCG2—Carboplatin—ovarian cancer	0.0341	0.0543	CbGbCtD
Nelfinavir—CYP3A7—Paclitaxel—ovarian cancer	0.0268	0.0426	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0268	0.0426	CbGbCtD
Nelfinavir—ABCB1—Topotecan—ovarian cancer	0.0264	0.0421	CbGbCtD
Nelfinavir—ABCG2—Docetaxel—ovarian cancer	0.0262	0.0417	CbGbCtD
Nelfinavir—CYP3A5—Paclitaxel—ovarian cancer	0.0201	0.032	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—ovarian cancer	0.0195	0.0311	CbGbCtD
Nelfinavir—CYP3A7—Docetaxel—ovarian cancer	0.0193	0.0308	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0193	0.0308	CbGbCtD
Nelfinavir—ABCB1—Vinorelbine—ovarian cancer	0.0186	0.0296	CbGbCtD
Nelfinavir—CYP2D6—Vinorelbine—ovarian cancer	0.0175	0.0279	CbGbCtD
Nelfinavir—CYP3A4—Topotecan—ovarian cancer	0.0158	0.0252	CbGbCtD
Nelfinavir—CYP3A5—Docetaxel—ovarian cancer	0.0145	0.0231	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—ovarian cancer	0.0137	0.0219	CbGbCtD
Nelfinavir—CYP2C9—Paclitaxel—ovarian cancer	0.0135	0.0215	CbGbCtD
Nelfinavir—ABCB1—Paclitaxel—ovarian cancer	0.0131	0.0208	CbGbCtD
Nelfinavir—CYP3A4—Vinorelbine—ovarian cancer	0.0111	0.0178	CbGbCtD
Nelfinavir—ABCB1—Docetaxel—ovarian cancer	0.00944	0.0151	CbGbCtD
Nelfinavir—CYP3A4—Paclitaxel—ovarian cancer	0.00783	0.0125	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—ovarian cancer	0.00704	0.0112	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—ovarian cancer	0.00663	0.0106	CbGbCtD
Nelfinavir—CYP3A4—Docetaxel—ovarian cancer	0.00566	0.00902	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—ovarian cancer	0.00422	0.00672	CbGbCtD
Nelfinavir—Indinavir—ABCB1—ovarian cancer	0.000317	0.572	CrCbGaD
Nelfinavir—Saquinavir—ABCB1—ovarian cancer	0.000237	0.427	CrCbGaD
Nelfinavir—Anaemia—Paclitaxel—ovarian cancer	0.000217	0.00146	CcSEcCtD
Nelfinavir—Erythema multiforme—Docetaxel—ovarian cancer	0.000216	0.00146	CcSEcCtD
Nelfinavir—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000216	0.00145	CcSEcCtD
Nelfinavir—Agitation—Paclitaxel—ovarian cancer	0.000216	0.00145	CcSEcCtD
Nelfinavir—Eye disorder—Docetaxel—ovarian cancer	0.000213	0.00144	CcSEcCtD
Nelfinavir—Vomiting—Topotecan—ovarian cancer	0.000211	0.00143	CcSEcCtD
Nelfinavir—Malaise—Paclitaxel—ovarian cancer	0.000211	0.00143	CcSEcCtD
Nelfinavir—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000211	0.00142	CcSEcCtD
Nelfinavir—Mood swings—Epirubicin—ovarian cancer	0.000211	0.00142	CcSEcCtD
Nelfinavir—Leukopenia—Paclitaxel—ovarian cancer	0.00021	0.00142	CcSEcCtD
Nelfinavir—Rash—Topotecan—ovarian cancer	0.00021	0.00141	CcSEcCtD
Nelfinavir—Hypersensitivity—Vinorelbine—ovarian cancer	0.00021	0.00141	CcSEcCtD
Nelfinavir—Dermatitis—Topotecan—ovarian cancer	0.00021	0.00141	CcSEcCtD
Nelfinavir—Headache—Topotecan—ovarian cancer	0.000208	0.00141	CcSEcCtD
Nelfinavir—Angiopathy—Docetaxel—ovarian cancer	0.000207	0.0014	CcSEcCtD
Nelfinavir—Vomiting—Melphalan—ovarian cancer	0.000207	0.0014	CcSEcCtD
Nelfinavir—Dehydration—Epirubicin—ovarian cancer	0.000207	0.0014	CcSEcCtD
Nelfinavir—Immune system disorder—Docetaxel—ovarian cancer	0.000206	0.00139	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000206	0.00139	CcSEcCtD
Nelfinavir—Liver function test abnormal—Epirubicin—ovarian cancer	0.000206	0.00139	CcSEcCtD
Nelfinavir—Rash—Melphalan—ovarian cancer	0.000205	0.00138	CcSEcCtD
Nelfinavir—Dermatitis—Melphalan—ovarian cancer	0.000205	0.00138	CcSEcCtD
Nelfinavir—Asthenia—Vinorelbine—ovarian cancer	0.000204	0.00138	CcSEcCtD
Nelfinavir—Abdominal pain upper—Epirubicin—ovarian cancer	0.000203	0.00137	CcSEcCtD
Nelfinavir—Convulsion—Paclitaxel—ovarian cancer	0.000203	0.00137	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—ovarian cancer	0.000203	0.00137	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—ovarian cancer	0.000203	0.00137	CcSEcCtD
Nelfinavir—Pruritus—Vinorelbine—ovarian cancer	0.000201	0.00136	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.0002	0.00135	CcSEcCtD
Nelfinavir—Arthralgia—Paclitaxel—ovarian cancer	0.0002	0.00135	CcSEcCtD
Nelfinavir—Myalgia—Paclitaxel—ovarian cancer	0.0002	0.00135	CcSEcCtD
Nelfinavir—Anxiety—Paclitaxel—ovarian cancer	0.000199	0.00134	CcSEcCtD
Nelfinavir—Malnutrition—Docetaxel—ovarian cancer	0.000199	0.00134	CcSEcCtD
Nelfinavir—Erythema—Docetaxel—ovarian cancer	0.000199	0.00134	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000198	0.00134	CcSEcCtD
Nelfinavir—Nausea—Topotecan—ovarian cancer	0.000198	0.00133	CcSEcCtD
Nelfinavir—Discomfort—Paclitaxel—ovarian cancer	0.000197	0.00133	CcSEcCtD
Nelfinavir—Muscular weakness—Epirubicin—ovarian cancer	0.000196	0.00132	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000196	0.00132	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—ovarian cancer	0.000195	0.00132	CcSEcCtD
Nelfinavir—Diarrhoea—Vinorelbine—ovarian cancer	0.000195	0.00131	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—ovarian cancer	0.000194	0.00131	CcSEcCtD
Nelfinavir—Nausea—Melphalan—ovarian cancer	0.000193	0.0013	CcSEcCtD
Nelfinavir—Back pain—Docetaxel—ovarian cancer	0.000192	0.0013	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—ovarian cancer	0.000192	0.00129	CcSEcCtD
Nelfinavir—Oedema—Paclitaxel—ovarian cancer	0.000191	0.00129	CcSEcCtD
Nelfinavir—Muscle spasms—Docetaxel—ovarian cancer	0.000191	0.00129	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00019	0.00128	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—ovarian cancer	0.000189	0.00127	CcSEcCtD
Nelfinavir—Dizziness—Vinorelbine—ovarian cancer	0.000188	0.00127	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000188	0.00127	CcSEcCtD
Nelfinavir—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000187	0.00126	CcSEcCtD
Nelfinavir—Skin disorder—Paclitaxel—ovarian cancer	0.000186	0.00125	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000185	0.00125	CcSEcCtD
Nelfinavir—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000185	0.00125	CcSEcCtD
Nelfinavir—Anaemia—Docetaxel—ovarian cancer	0.000184	0.00124	CcSEcCtD
Nelfinavir—Anorexia—Paclitaxel—ovarian cancer	0.000182	0.00123	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—ovarian cancer	0.000182	0.00123	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000182	0.00123	CcSEcCtD
Nelfinavir—Vomiting—Vinorelbine—ovarian cancer	0.000181	0.00122	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—ovarian cancer	0.00018	0.00121	CcSEcCtD
Nelfinavir—Rash—Vinorelbine—ovarian cancer	0.000179	0.00121	CcSEcCtD
Nelfinavir—Dermatitis—Vinorelbine—ovarian cancer	0.000179	0.00121	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—ovarian cancer	0.000179	0.00121	CcSEcCtD
Nelfinavir—Headache—Vinorelbine—ovarian cancer	0.000178	0.0012	CcSEcCtD
Nelfinavir—Leukopenia—Docetaxel—ovarian cancer	0.000178	0.0012	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—ovarian cancer	0.000175	0.00118	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000174	0.00118	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—ovarian cancer	0.000174	0.00117	CcSEcCtD
Nelfinavir—Insomnia—Paclitaxel—ovarian cancer	0.000173	0.00117	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—ovarian cancer	0.000173	0.00116	CcSEcCtD
Nelfinavir—Convulsion—Docetaxel—ovarian cancer	0.000172	0.00116	CcSEcCtD
Nelfinavir—Paraesthesia—Paclitaxel—ovarian cancer	0.000172	0.00116	CcSEcCtD
Nelfinavir—Dyspnoea—Paclitaxel—ovarian cancer	0.000171	0.00115	CcSEcCtD
Nelfinavir—Somnolence—Paclitaxel—ovarian cancer	0.00017	0.00115	CcSEcCtD
Nelfinavir—Myalgia—Docetaxel—ovarian cancer	0.000169	0.00114	CcSEcCtD
Nelfinavir—Arthralgia—Docetaxel—ovarian cancer	0.000169	0.00114	CcSEcCtD
Nelfinavir—Nausea—Vinorelbine—ovarian cancer	0.000169	0.00114	CcSEcCtD
Nelfinavir—Dyspepsia—Paclitaxel—ovarian cancer	0.000168	0.00114	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000168	0.00113	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—ovarian cancer	0.000167	0.00113	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—ovarian cancer	0.000167	0.00113	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—ovarian cancer	0.000166	0.00112	CcSEcCtD
Nelfinavir—Decreased appetite—Paclitaxel—ovarian cancer	0.000166	0.00112	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000165	0.00111	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—ovarian cancer	0.000164	0.00111	CcSEcCtD
Nelfinavir—Pain—Paclitaxel—ovarian cancer	0.000164	0.0011	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000162	0.00109	CcSEcCtD
Nelfinavir—Oedema—Docetaxel—ovarian cancer	0.000162	0.00109	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—ovarian cancer	0.000162	0.00109	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—ovarian cancer	0.000161	0.00109	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000161	0.00108	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—ovarian cancer	0.00016	0.00108	CcSEcCtD
Nelfinavir—Thrombocytopenia—Docetaxel—ovarian cancer	0.000159	0.00107	CcSEcCtD
Nelfinavir—Feeling abnormal—Paclitaxel—ovarian cancer	0.000158	0.00106	CcSEcCtD
Nelfinavir—Skin disorder—Docetaxel—ovarian cancer	0.000158	0.00106	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000157	0.00106	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—ovarian cancer	0.000155	0.00104	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—ovarian cancer	0.000155	0.00104	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—ovarian cancer	0.000155	0.00104	CcSEcCtD
Nelfinavir—Anorexia—Docetaxel—ovarian cancer	0.000155	0.00104	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—ovarian cancer	0.000154	0.00104	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—ovarian cancer	0.000154	0.00104	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—ovarian cancer	0.000154	0.00104	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—ovarian cancer	0.000153	0.00103	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—ovarian cancer	0.000152	0.00103	CcSEcCtD
Nelfinavir—Urticaria—Paclitaxel—ovarian cancer	0.000152	0.00103	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—ovarian cancer	0.000151	0.00102	CcSEcCtD
Nelfinavir—Abdominal pain—Paclitaxel—ovarian cancer	0.000151	0.00102	CcSEcCtD
Nelfinavir—Body temperature increased—Paclitaxel—ovarian cancer	0.000151	0.00102	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00015	0.00101	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—ovarian cancer	0.00015	0.00101	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—ovarian cancer	0.000149	0.001	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000148	0.000997	CcSEcCtD
Nelfinavir—Insomnia—Docetaxel—ovarian cancer	0.000147	0.000989	CcSEcCtD
Nelfinavir—Paraesthesia—Docetaxel—ovarian cancer	0.000146	0.000982	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—ovarian cancer	0.000146	0.000982	CcSEcCtD
Nelfinavir—Dyspnoea—Docetaxel—ovarian cancer	0.000145	0.000975	CcSEcCtD
Nelfinavir—Somnolence—Docetaxel—ovarian cancer	0.000144	0.000972	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—ovarian cancer	0.000144	0.000971	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—ovarian cancer	0.000143	0.000966	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—ovarian cancer	0.000143	0.000963	CcSEcCtD
Nelfinavir—Dyspepsia—Docetaxel—ovarian cancer	0.000143	0.000963	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—ovarian cancer	0.000143	0.000961	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—ovarian cancer	0.000143	0.000961	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—ovarian cancer	0.000141	0.000954	CcSEcCtD
Nelfinavir—Decreased appetite—Docetaxel—ovarian cancer	0.000141	0.000951	CcSEcCtD
Nelfinavir—Hypersensitivity—Paclitaxel—ovarian cancer	0.000141	0.000951	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00014	0.000944	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00014	0.000944	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—ovarian cancer	0.00014	0.000942	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—ovarian cancer	0.000139	0.000938	CcSEcCtD
Nelfinavir—Pain—Docetaxel—ovarian cancer	0.000139	0.000935	CcSEcCtD
Nelfinavir—Asthenia—Paclitaxel—ovarian cancer	0.000137	0.000926	CcSEcCtD
Nelfinavir—Pruritus—Paclitaxel—ovarian cancer	0.000135	0.000913	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—ovarian cancer	0.000135	0.000909	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—ovarian cancer	0.000134	0.000904	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—ovarian cancer	0.000134	0.000904	CcSEcCtD
Nelfinavir—Feeling abnormal—Docetaxel—ovarian cancer	0.000134	0.000901	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—ovarian cancer	0.000133	0.000898	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000133	0.000894	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—ovarian cancer	0.000132	0.000891	CcSEcCtD
Nelfinavir—Diarrhoea—Paclitaxel—ovarian cancer	0.000131	0.000883	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—ovarian cancer	0.00013	0.000874	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—ovarian cancer	0.000129	0.000872	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—ovarian cancer	0.000129	0.000869	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—ovarian cancer	0.000129	0.000868	CcSEcCtD
Nelfinavir—Body temperature increased—Docetaxel—ovarian cancer	0.000128	0.000865	CcSEcCtD
Nelfinavir—Abdominal pain—Docetaxel—ovarian cancer	0.000128	0.000865	CcSEcCtD
Nelfinavir—Dizziness—Paclitaxel—ovarian cancer	0.000127	0.000853	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—ovarian cancer	0.000124	0.000839	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—ovarian cancer	0.000124	0.000836	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—ovarian cancer	0.000124	0.000836	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—ovarian cancer	0.000124	0.000836	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—ovarian cancer	0.000123	0.000831	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—ovarian cancer	0.000122	0.000824	CcSEcCtD
Nelfinavir—Vomiting—Paclitaxel—ovarian cancer	0.000122	0.000821	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—ovarian cancer	0.000121	0.000815	CcSEcCtD
Nelfinavir—Rash—Paclitaxel—ovarian cancer	0.000121	0.000814	CcSEcCtD
Nelfinavir—Dermatitis—Paclitaxel—ovarian cancer	0.000121	0.000813	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—ovarian cancer	0.00012	0.000809	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—ovarian cancer	0.00012	0.000809	CcSEcCtD
Nelfinavir—Headache—Paclitaxel—ovarian cancer	0.00012	0.000808	CcSEcCtD
Nelfinavir—Hypersensitivity—Docetaxel—ovarian cancer	0.00012	0.000806	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—ovarian cancer	0.000119	0.000804	CcSEcCtD
Nelfinavir—Asthenia—Docetaxel—ovarian cancer	0.000116	0.000785	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—ovarian cancer	0.000116	0.000783	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000115	0.000776	CcSEcCtD
Nelfinavir—Pruritus—Docetaxel—ovarian cancer	0.000115	0.000774	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—ovarian cancer	0.000115	0.000773	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—ovarian cancer	0.000114	0.00077	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—ovarian cancer	0.000114	0.00077	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—ovarian cancer	0.000114	0.000769	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—ovarian cancer	0.000114	0.000767	CcSEcCtD
Nelfinavir—Nausea—Paclitaxel—ovarian cancer	0.000114	0.000767	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000113	0.000764	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—ovarian cancer	0.000113	0.00076	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—ovarian cancer	0.000112	0.000754	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—ovarian cancer	0.000111	0.000749	CcSEcCtD
Nelfinavir—Diarrhoea—Docetaxel—ovarian cancer	0.000111	0.000748	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—ovarian cancer	0.000109	0.000738	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—ovarian cancer	0.000107	0.000725	CcSEcCtD
Nelfinavir—Dizziness—Docetaxel—ovarian cancer	0.000107	0.000723	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—ovarian cancer	0.000107	0.000722	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—ovarian cancer	0.000106	0.000717	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—ovarian cancer	0.000106	0.000713	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—ovarian cancer	0.000106	0.000712	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—ovarian cancer	0.000106	0.000712	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—ovarian cancer	0.000105	0.00071	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000105	0.000707	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—ovarian cancer	0.000104	0.000704	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—ovarian cancer	0.000104	0.000703	CcSEcCtD
Nelfinavir—Vomiting—Docetaxel—ovarian cancer	0.000103	0.000696	CcSEcCtD
Nelfinavir—Rash—Docetaxel—ovarian cancer	0.000102	0.00069	CcSEcCtD
Nelfinavir—Dermatitis—Docetaxel—ovarian cancer	0.000102	0.000689	CcSEcCtD
Nelfinavir—Headache—Docetaxel—ovarian cancer	0.000102	0.000685	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—ovarian cancer	0.000101	0.000683	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.97e-05	0.000672	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—ovarian cancer	9.91e-05	0.000668	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—ovarian cancer	9.9e-05	0.000667	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—ovarian cancer	9.83e-05	0.000663	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—ovarian cancer	9.83e-05	0.000663	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—ovarian cancer	9.79e-05	0.00066	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—ovarian cancer	9.76e-05	0.000658	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—ovarian cancer	9.73e-05	0.000656	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—ovarian cancer	9.65e-05	0.000651	CcSEcCtD
Nelfinavir—Nausea—Docetaxel—ovarian cancer	9.64e-05	0.00065	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—ovarian cancer	9.63e-05	0.000649	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—ovarian cancer	9.51e-05	0.000641	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.45e-05	0.000637	CcSEcCtD
Nelfinavir—Pain—Epirubicin—ovarian cancer	9.36e-05	0.000631	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.22e-05	0.000622	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—ovarian cancer	9.16e-05	0.000617	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—ovarian cancer	9.09e-05	0.000613	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—ovarian cancer	9.03e-05	0.000609	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—ovarian cancer	9.02e-05	0.000608	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—ovarian cancer	9e-05	0.000607	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—ovarian cancer	8.95e-05	0.000603	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—ovarian cancer	8.91e-05	0.000601	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—ovarian cancer	8.8e-05	0.000593	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.74e-05	0.000589	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—ovarian cancer	8.69e-05	0.000586	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—ovarian cancer	8.66e-05	0.000584	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—ovarian cancer	8.65e-05	0.000583	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—ovarian cancer	8.65e-05	0.000583	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—ovarian cancer	8.34e-05	0.000563	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.28e-05	0.000558	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—ovarian cancer	8.06e-05	0.000544	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—ovarian cancer	8.04e-05	0.000542	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—ovarian cancer	8e-05	0.00054	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—ovarian cancer	8e-05	0.00054	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—ovarian cancer	7.85e-05	0.000529	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—ovarian cancer	7.74e-05	0.000522	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—ovarian cancer	7.49e-05	0.000505	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—ovarian cancer	7.46e-05	0.000503	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—ovarian cancer	7.26e-05	0.00049	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—ovarian cancer	7.24e-05	0.000488	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—ovarian cancer	7.16e-05	0.000483	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—ovarian cancer	6.96e-05	0.000469	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—ovarian cancer	6.93e-05	0.000467	CcSEcCtD
Nelfinavir—Rash—Epirubicin—ovarian cancer	6.9e-05	0.000465	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—ovarian cancer	6.89e-05	0.000465	CcSEcCtD
Nelfinavir—Headache—Epirubicin—ovarian cancer	6.85e-05	0.000462	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—ovarian cancer	6.7e-05	0.000451	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—ovarian cancer	6.5e-05	0.000438	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—ovarian cancer	6.44e-05	0.000434	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—ovarian cancer	6.38e-05	0.00043	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—ovarian cancer	6.38e-05	0.00043	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—ovarian cancer	6.34e-05	0.000428	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—ovarian cancer	6.01e-05	0.000406	CcSEcCtD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.44e-06	0.000598	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.43e-06	0.000597	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—YAP1—ovarian cancer	7.43e-06	0.000597	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYTB—ovarian cancer	7.42e-06	0.000596	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	7.42e-06	0.000596	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.33e-06	0.000589	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	7.27e-06	0.000584	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.2e-06	0.000578	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NME2—ovarian cancer	7.1e-06	0.00057	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—FASN—ovarian cancer	7.09e-06	0.000569	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	7.08e-06	0.000568	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	7.01e-06	0.000563	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—MAPK1—ovarian cancer	7e-06	0.000562	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYTB—ovarian cancer	7e-06	0.000562	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	6.97e-06	0.00056	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYTB—ovarian cancer	6.94e-06	0.000557	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	6.83e-06	0.000549	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.78e-06	0.000545	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	6.73e-06	0.000541	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	6.69e-06	0.000538	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.66e-06	0.000535	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—BRIP1—ovarian cancer	6.65e-06	0.000534	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPP1CC—ovarian cancer	6.65e-06	0.000534	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.59e-06	0.00053	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—FASN—ovarian cancer	6.56e-06	0.000527	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—FASN—ovarian cancer	6.5e-06	0.000523	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPP1CC—ovarian cancer	6.49e-06	0.000521	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—BRIP1—ovarian cancer	6.49e-06	0.000521	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	6.45e-06	0.000519	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—SLC5A5—ovarian cancer	6.45e-06	0.000519	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—SLC5A5—ovarian cancer	6.4e-06	0.000514	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.36e-06	0.000511	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—SLC2A1—ovarian cancer	6.23e-06	0.000501	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—ABCB1—ovarian cancer	6.22e-06	0.000499	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—SLC2A1—ovarian cancer	6.18e-06	0.000496	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	6.17e-06	0.000496	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—BRIP1—ovarian cancer	6.11e-06	0.000491	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPP1CC—ovarian cancer	6.11e-06	0.000491	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—TYMS—ovarian cancer	6.1e-06	0.00049	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—BRIP1—ovarian cancer	6.06e-06	0.000487	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPP1CC—ovarian cancer	6.06e-06	0.000487	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—FASN—ovarian cancer	6.05e-06	0.000486	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP1B1—ovarian cancer	5.98e-06	0.00048	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—SLC5A5—ovarian cancer	5.95e-06	0.000478	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYTB—ovarian cancer	5.93e-06	0.000476	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP1B1—ovarian cancer	5.92e-06	0.000476	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—YAP1—ovarian cancer	5.9e-06	0.000474	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	5.84e-06	0.000469	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.79e-06	0.000465	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—YAP1—ovarian cancer	5.77e-06	0.000463	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—SLC2A1—ovarian cancer	5.75e-06	0.000462	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	5.72e-06	0.00046	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.7e-06	0.000458	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.68e-06	0.000456	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—HRAS—ovarian cancer	5.62e-06	0.000451	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.55e-06	0.000446	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.55e-06	0.000446	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP1B1—ovarian cancer	5.51e-06	0.000443	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ABCB1—ovarian cancer	5.32e-06	0.000427	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PPP2R1A—ovarian cancer	5.3e-06	0.000426	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	5.25e-06	0.000422	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.24e-06	0.000421	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—TYMS—ovarian cancer	5.22e-06	0.000419	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—BRIP1—ovarian cancer	5.18e-06	0.000416	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPP1CC—ovarian cancer	5.18e-06	0.000416	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ABCB1—ovarian cancer	4.92e-06	0.000395	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CAV1—ovarian cancer	4.92e-06	0.000395	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	4.89e-06	0.000393	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ABCB1—ovarian cancer	4.88e-06	0.000392	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.84e-06	0.000389	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—TYMS—ovarian cancer	4.83e-06	0.000388	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.82e-06	0.000387	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—FASN—ovarian cancer	4.81e-06	0.000386	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—TYMS—ovarian cancer	4.79e-06	0.000385	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—SLC5A5—ovarian cancer	4.73e-06	0.00038	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—FASN—ovarian cancer	4.7e-06	0.000378	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.7e-06	0.000378	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.66e-06	0.000374	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—SLC5A5—ovarian cancer	4.62e-06	0.000372	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYTB—ovarian cancer	4.57e-06	0.000367	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—SLC2A1—ovarian cancer	4.57e-06	0.000367	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ABCB1—ovarian cancer	4.54e-06	0.000365	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	4.48e-06	0.00036	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—SLC2A1—ovarian cancer	4.47e-06	0.000359	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—YAP1—ovarian cancer	4.46e-06	0.000358	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—TYMS—ovarian cancer	4.46e-06	0.000358	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.42e-06	0.000355	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.41e-06	0.000355	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP1B1—ovarian cancer	4.38e-06	0.000352	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—YAP1—ovarian cancer	4.35e-06	0.00035	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP1B1—ovarian cancer	4.28e-06	0.000344	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CAV1—ovarian cancer	4.21e-06	0.000338	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—YAP1—ovarian cancer	4.1e-06	0.00033	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—YAP1—ovarian cancer	4.07e-06	0.000327	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.02e-06	0.000323	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.02e-06	0.000323	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—BRIP1—ovarian cancer	4e-06	0.000321	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4e-06	0.000321	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	3.94e-06	0.000316	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.94e-06	0.000316	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CAV1—ovarian cancer	3.89e-06	0.000313	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	3.89e-06	0.000312	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.88e-06	0.000312	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CAV1—ovarian cancer	3.86e-06	0.00031	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	3.83e-06	0.000308	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	3.8e-06	0.000305	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.77e-06	0.000303	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—FASN—ovarian cancer	3.63e-06	0.000292	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ABCB1—ovarian cancer	3.61e-06	0.00029	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CAV1—ovarian cancer	3.59e-06	0.000289	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3.58e-06	0.000287	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—FASN—ovarian cancer	3.55e-06	0.000285	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CG—ovarian cancer	3.55e-06	0.000285	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—TYMS—ovarian cancer	3.54e-06	0.000285	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.54e-06	0.000284	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ABCB1—ovarian cancer	3.53e-06	0.000283	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CG—ovarian cancer	3.52e-06	0.000283	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—SLC5A5—ovarian cancer	3.49e-06	0.00028	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—YAP1—ovarian cancer	3.47e-06	0.000279	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—TYMS—ovarian cancer	3.46e-06	0.000278	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—SLC2A1—ovarian cancer	3.45e-06	0.000277	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.44e-06	0.000276	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	3.43e-06	0.000276	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.38e-06	0.000272	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—SLC2A1—ovarian cancer	3.37e-06	0.000271	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	3.37e-06	0.000271	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—FASN—ovarian cancer	3.34e-06	0.000269	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—FASN—ovarian cancer	3.31e-06	0.000266	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1B1—ovarian cancer	3.31e-06	0.000266	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SLC5A5—ovarian cancer	3.29e-06	0.000264	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CG—ovarian cancer	3.27e-06	0.000263	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SLC5A5—ovarian cancer	3.26e-06	0.000262	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1B1—ovarian cancer	3.23e-06	0.00026	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SLC2A1—ovarian cancer	3.18e-06	0.000255	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SLC2A1—ovarian cancer	3.15e-06	0.000253	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CD—ovarian cancer	3.12e-06	0.000251	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CD—ovarian cancer	3.09e-06	0.000248	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.08e-06	0.000248	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1B1—ovarian cancer	3.04e-06	0.000245	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.02e-06	0.000243	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.02e-06	0.000243	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—ovarian cancer	2.97e-06	0.000238	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.94e-06	0.000236	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	2.94e-06	0.000236	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.92e-06	0.000235	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CD—ovarian cancer	2.88e-06	0.000231	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPP2R1A—ovarian cancer	2.87e-06	0.00023	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CAV1—ovarian cancer	2.86e-06	0.000229	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—FASN—ovarian cancer	2.83e-06	0.000228	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CAV1—ovarian cancer	2.79e-06	0.000224	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.79e-06	0.000224	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.73e-06	0.000219	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CB—ovarian cancer	2.72e-06	0.000218	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	2.7e-06	0.000217	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CB—ovarian cancer	2.69e-06	0.000216	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.69e-06	0.000216	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—YAP1—ovarian cancer	2.68e-06	0.000215	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TYMS—ovarian cancer	2.68e-06	0.000215	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	2.68e-06	0.000215	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.66e-06	0.000214	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.63e-06	0.000212	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TYMS—ovarian cancer	2.61e-06	0.00021	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CG—ovarian cancer	2.6e-06	0.000209	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.58e-06	0.000207	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CG—ovarian cancer	2.54e-06	0.000204	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—ovarian cancer	2.54e-06	0.000204	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CB—ovarian cancer	2.51e-06	0.000201	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ABCB1—ovarian cancer	2.51e-06	0.000201	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.49e-06	0.0002	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TYMS—ovarian cancer	2.46e-06	0.000198	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TYMS—ovarian cancer	2.44e-06	0.000196	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—ovarian cancer	2.35e-06	0.000189	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—ovarian cancer	2.33e-06	0.000187	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.29e-06	0.000184	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CD—ovarian cancer	2.29e-06	0.000184	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.28e-06	0.000183	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CD—ovarian cancer	2.23e-06	0.00018	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—FASN—ovarian cancer	2.19e-06	0.000176	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—ovarian cancer	2.17e-06	0.000174	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CAV1—ovarian cancer	2.16e-06	0.000173	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.15e-06	0.000173	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.12e-06	0.000171	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CAV1—ovarian cancer	2.11e-06	0.000169	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	2.09e-06	0.000168	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TYMS—ovarian cancer	2.09e-06	0.000168	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.08e-06	0.000167	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.06e-06	0.000166	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.99e-06	0.00016	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.99e-06	0.00016	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CAV1—ovarian cancer	1.98e-06	0.000159	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CAV1—ovarian cancer	1.97e-06	0.000158	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.97e-06	0.000158	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CB—ovarian cancer	1.95e-06	0.000156	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.92e-06	0.000154	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.88e-06	0.000151	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.81e-06	0.000145	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.79e-06	0.000144	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	1.79e-06	0.000144	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.77e-06	0.000142	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.73e-06	0.000139	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—ovarian cancer	1.72e-06	0.000138	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—ovarian cancer	1.71e-06	0.000137	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.69e-06	0.000135	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—ovarian cancer	1.68e-06	0.000135	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CAV1—ovarian cancer	1.68e-06	0.000135	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—ovarian cancer	1.66e-06	0.000133	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—ovarian cancer	1.64e-06	0.000132	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.64e-06	0.000132	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TYMS—ovarian cancer	1.61e-06	0.000129	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.61e-06	0.000129	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.59e-06	0.000128	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.58e-06	0.000127	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.53e-06	0.000123	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—ovarian cancer	1.53e-06	0.000123	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.51e-06	0.000121	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.47e-06	0.000118	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.46e-06	0.000117	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.39e-06	0.000111	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.37e-06	0.00011	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—ovarian cancer	1.35e-06	0.000109	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.35e-06	0.000108	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—ovarian cancer	1.34e-06	0.000108	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—ovarian cancer	1.3e-06	0.000105	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CAV1—ovarian cancer	1.3e-06	0.000104	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—ovarian cancer	1.27e-06	0.000102	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—ovarian cancer	1.25e-06	0.0001	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.21e-06	9.76e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—ovarian cancer	1.2e-06	9.62e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.19e-06	9.54e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—ovarian cancer	1.19e-06	9.53e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.18e-06	9.49e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.17e-06	9.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.04e-06	8.35e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—ovarian cancer	1.01e-06	8.15e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—ovarian cancer	9.92e-07	7.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—ovarian cancer	9.7e-07	7.79e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—ovarian cancer	9.18e-07	7.38e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CB—ovarian cancer	9.06e-07	7.28e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—ovarian cancer	8.96e-07	7.2e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—ovarian cancer	8.44e-07	6.78e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—ovarian cancer	8.37e-07	6.72e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—ovarian cancer	7.82e-07	6.29e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—ovarian cancer	7.5e-07	6.03e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—ovarian cancer	7.32e-07	5.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—ovarian cancer	7.15e-07	5.75e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—ovarian cancer	6.9e-07	5.54e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—ovarian cancer	6.84e-07	5.49e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—ovarian cancer	5.84e-07	4.69e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.52e-07	4.44e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—ovarian cancer	4.51e-07	3.62e-05	CbGpPWpGaD
